Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
209 Leser
Artikel bewerten:
(0)

Billy McLaughlin Elected to Dystonia Medical Research Foundation Board of Directors

CHICAGO, Aug. 25, 2011 /PRNewswire-USNewswire/ -- Critically-acclaimed guitarist and composer Billy McLaughlin is the newest member to join the board of the Dystonia Medical Research Foundation (DMRF), a non-profit organization that serves individuals impacted by dystonia, a neurological disease.

"The DMRF is an organization that's making great progress in research to better understand and cure this disorder-and to bring visibility to the devastating impact of dystonia on those of us who are diagnosed," says McLaughlin. "I'm thrilled to continue being a part of this work."

McLaughlin, a Minneapolis native, began developing his signature sound at the University of Southern California. Employing his unique style of placing both hands on the fretboard, he began composing for his first release by creating a harp-like effect on the acoustic guitar. This unusual approach led McLaughlin to extensive national touring and multiple NACA Campus Entertainer awards. In 1995 McLaughlin signed a multi-album, international contract with the Virgin Records label Narada whose first release, Fingerdance, peaked at #7 on the Billboard charts. Hundreds of shows a year and deep into his contract, he began struggling with his hands.

For two years, McLaughlin grappled with mysterious and unrelenting muscle spasms in his left hand. As symptoms grew worse he could no longer perform most of his own repertoire. In 2001, McLaughlin was diagnosed with focal hand dystonia. Against doctors' recommendations, McLaughlin began the daunting journey of teaching himself to play in his signature style, left-handed. In 2004 a film crew began following McLaughlin's desperate attempt to regain his career. In 2007, Billy published a limited release of Into the Light, a concert recording of compositions for acoustic guitar with string orchestra, and his first recording as a left-handed guitarist.

"Billy is as energetic and enthusiastic about making life better for people with dystonia as he is about his music, which is truly inspiring. It's an honor for the DMRF to have him be a part of our team," says Executive Director Janet Hieshetter.

McLaughlin was appointed DMRF's Ambassador of Awareness in 2009 for his efforts to educate the public about dystonia. The documentary about his journey, Changing Keys, began airing on PBS stations across the country in 2010. That same year, he received the American Academy of Neurology Leadership in Public Neurology Award. McLaughlin is a frequent speaker at DMRF events, founded a support group, and has been an active legislative advocate on behalf of the dystonia community for the past two years.

Dystonia is a movement disorder that causes muscles to contract and spasm involuntarily resulting in twisting, repetitive movements and abnormal postures. Dystonia may be generalized, affecting multiple muscle groups, or focal, affecting a specific part of the body. There is no known cure.

Founded in 1976, the Dystonia Medical Research Foundation is a 501c3 organization whose mission is to advance research toward improved treatments and a cure, promoting education and awareness, and providing support resources to affected individuals and families. The organization can be reached at http://www.dystonia-foundation.org or 800-377-DYST (3978).

Contact: Jessica Feeley, Ph: 912-510-0337, jfeeley@dystonia-foundation.org

SOURCE Dystonia Medical Research Foundation

© 2011 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.